← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Emergent Product Development Gaithersbur
Gaithersburg, MD
$136,650,885
Total funding
14
Grants
Funding over time
peak $24.1M · FY2006–23$25M$18.8M$12.5M$6.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$136,650,885 · 14
By mechanism
N01$108,604,848 · 5
U01$13,679,698 · 5
R01$7,676,123 · 1
UG3$6,354,906 · 1
R34$335,310 · 2
Investigators at Emergent Product Development Gaithersbur
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of Technologies to Facilitate the Use of and Response to Vaccines$14,455,413
N01 · FY2012 · AI
Development of an Anthrax Vaccine$13,072,863
N01 · FY2008 · AI
Development of an Anthrax Vaccine$11,351,920
N01 · FY2010 · AI
Development of Technologies to Facilitate the Use of and Response to Vaccines$10,928,292
N01 · FY2014 · AI
Development of Technologies to Facilitate the Use of and Response to Vaccines$9,113,435
N01 · FY2010 · AI
DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N$8,677,955
N01 · FY2017 · AI
DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N$7,386,039
N01 · FY2014 · AI
Nalmefene Long-Acting Injectable (AP007) for the Treatment of Opioid Use Disorder$6,354,906
UG3 · FY2019 · DA
Development of Monoclonal Antibody Therapeutics for Anthrax$5,312,801
N01 · FY2008 · AI
DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N$4,181,877
N01 · FY2016 · AI
DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N$3,844,268
N01 · FY2019 · AI
DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N$3,233,217
N01 · FY2015 · AI
Development of a Next Generation Anthrax Vaccine, dmPA7909$2,896,688
U01 · FY2010 · AI
Development of Technologies to Facilitate the Use of and Response to Vaccines$2,739,889
N01 · FY2020 · AI
Development of an Anthrax Vaccine$2,562,540
N01 · FY2021 · AI
DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N$2,484,726
N01 · FY2018 · AI
Development of a Next Generation Anthrax Vaccine, dmPA7909$2,454,564
U01 · FY2009 · AI
Development of Technologies to Facilitate the Use of and Response to Vaccines$2,045,144
N01 · FY2013 · AI
Anthrax Immune Globulin to Prevent & Treat Anthrax: Advanced Product Development$1,998,521
U01 · FY2006 · AI
Development of Human Anthrax Immune Globulin$1,928,811
N01 · FY2011 · AI